Bio-Rad has appointed Louis Drapeau to the company’s board of directors.
Drapeau will also serve on the board’s audit committee.
He is currently CFO of Nektar Therapeutics, a drug-development firm that recently named former Sirna Therapeutics head Howard Robin as its president and CEO.
Previously, Drapeau held various executive positions at BioMarin Pharmaceutical. He holds a BS in mechanical engineering and an MBA from Stanford University.